Keywords: واکسن BCG; urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
مقالات ISI واکسن BCG (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن BCG; Tuberculosis pulmonar; Infección latente; Macrófagos activados; Inmunidad mediada por células; Hipersensibilidad de tipo tardÃo; Vacuna BCG; Tuberculosis resistente a fármacos; Pulmonary tuberculosis; Latent infection; Activated macrophages; Cell-med
Keywords: واکسن BCG; BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: واکسن BCG; urinary bladder neoplasms; administration; intravesical; BCG vaccine; mitomycin; interferons; BCG; bacillus Calmette-Guérin; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; SOE; strength of evidence; TURBT; transurethral bladder tumor resecti
Keywords: واکسن BCG; bladder neoplasms; risk assessment; practice guidelines as topic; mortality; BCG vaccine; BCG; bacillus Calmette-Guérin; CUETO; Club Urológico Español de Tratamiento Oncológico; EORTC; European Organization for Research and Treatment of Cancer; NCCN®
Keywords: واکسن BCG; BCG vaccine; Mycobacterium tuberculosis; Prevention; TB; Tuberculosis; Vaccine;
Keywords: واکسن BCG; Tuberculose; Enfant; BCG; Tuberculose latente; Test de production de l'interféron gamma; Traitement; Tuberculosis; Childhood; BCG vaccine; Latent tuberculosis; Interferon-gamma release test; Treatment;
Keywords: واکسن BCG; urinary bladder neoplasms; disease progression; BCG vaccine; drug therapy; administration; intravesicalBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer; TURBT, transurethral resection of the
Keywords: واکسن BCG; Models-Theoretical; Tuberculosis-Multidrug Resistant; Disease Transmission-Infectious; Latent tuberculosis; BCG vaccine;
Keywords: واکسن BCG; BCG vaccine; Immunotherapy; Cancer
The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma
Keywords: واکسن BCG; urinary bladder neoplasms; carcinoma; polymorphism; single nucleotide; receptors; calcitriol; BCG vaccine; 1,25-VD; activated vitamin D; BCG; bacillus Calmette-Guérin; NMIBC; nonmuscle invasive bladder cancer; PCR; polymerase chain reaction; SNP; single
BCGites après immunothérapie pour cancer de vessie, une pathologie hétérogène: physiopathologie, description clinique, prise en charge diagnostique et thérapeutique
Keywords: واکسن BCG; Tumeur de la vessie; Vaccin BCG; Infections à mycobactéries non tuberculeuses; Urinary bladder neoplasms; BCG vaccine; Mycobacterium infections; Non-tuberculous Mycobacterium infection;
Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; adjuvants; immunologic; skin tests; adverse effects; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; LUTS; lower urinary tract symptoms; NMIBC; nonmuscle invasive bladder cancer; PFS; progression-free surviv
Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer
Keywords: واکسن BCG; Urinary bladder neoplasms; Mycobacterium bovis; BCG vaccine; BCG Connaught; Adjuvant immunologic;
Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974
Keywords: واکسن BCG; BCG vaccine; Skin test; Vaccination; Immunization; Registries; Québec;
Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; immunotherapy; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; FDA; United States Food and Drug Administration; MeSH; Medical Subject Headings; NMIBC; nonmuscle invasive bladder cancer; PRISMA; Preferred Rep
Original ArticleComparing the effect of swaddling and breastfeeding and their combined effect on the pain induced by BCG vaccination in infants referring to Motahari Hospital, Jahrom, 2010-2011
Keywords: واکسن BCG; Swaddling; Breastfeeding; Pain; BCG vaccine; Neonates;
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer
Keywords: واکسن BCG; T1G3; bladder cancer; high grade; progression; recurrence; BCG Connaught; BCG Tice; BCG vaccine; Immunotherapy; Intravesical drug administration;
Different effects of BCG strains - A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau
Keywords: واکسن BCG; Non-specific/heterologous effects of vaccines; BCG vaccine; BCG strain; BCG scar; Child morbidity;
FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; fibroblast growth factors; receptors, fibroblast growth factor; biological markersBC, bladder cancer; BCG, bacillus Calmette-Guérin; FBS, fetal bovine serum; GAPDH, glyceraldehyde-3-phosphate-dehydrogenase; NMI, non
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; treatment failure; cystectomy; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CSS; cancer specific survival; HG; high grade; IFN; interferon; IVT; intravesical therapy; LVI; lymphovascular invasi
Does effect of BCG vaccine decrease with time since vaccination and increase tuberculin skin test reaction?
Keywords: واکسن BCG; BCG vaccine; Relative risk; Tuberculin skin test; Protective efficacy; Tuberculosis;
Hépatite granulomateuse révélant une infection disséminée à Mycobacterium bovis après BCG-thérapie intravésicale
Keywords: واکسن BCG; BCG; Immunothérapie; Hépatite; Granulomatose disséminée; BCG vaccine; Immunotherapy; Hepatitis; Granulomatosis;
Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme
Keywords: واکسن BCG; Immunisation programme; Selective vaccination; BCG vaccine; Tuberculosis; Hepatitis B vaccine; Immunisation registry;
Clinical Outcomes of cT1 Micropapillary Bladder Cancer
Keywords: واکسن BCG; urinary bladder; BCG vaccine; cystectomy; neoplasm invasiveness; mortalityBCG, bacillus Calmette-Guérin; DSS, disease specific survival; MPBC, micropapillary bladder cancer; NAC, neoadjuvant chemotherapy; NMI, nonmuscle invasive; TUR, transurethral resect
Management of Bacillus Calmette-Guérin osteomyelitis/osteitis in immunocompetent children-A systematic review
Keywords: واکسن BCG; BCG vaccine; Osteomyelitis; Osteitis; Disease management; Review;
Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infants
Keywords: واکسن BCG; BCG vaccine; T cell; Tetanus; Pertussis; Infants; HIV;
Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; treatment failure; Mycobacterium phlei; nucleic acidsAE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; DFS, disease-free survival; ITT, intent to treat; MCNA, Mycobacte
The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guérin
Keywords: واکسن BCG; urinary bladder; carcinoma; BCG vaccine; neoplasm recurrence; local; reoperationBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder carcinoma; TUR, transurethral resection
Comparison of Tuberculin Skin Test result and interferon gamma response to human PPD in BCG scar positive and negative children
Keywords: واکسن BCG; BCG vaccine; Human PPD; Interferon Gamma Release Assay; Tuberculin Skin Test; Vaccine scar
Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; cystectomy; treatment outcomeBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CSM, cancer specific mortality; CSS, cancer specific survival; LVI, lymphovascular invasion; MPC, micropapillary component; NED, no
Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer
Keywords: واکسن BCG; urinary bladder neoplasms; drug therapy; body temperature changes; BCG vaccine; neoplasm recurrence; localAE, adverse event; BCG, bacillus Calmette-Guérin; CHT, chemohyperthermia; CIS, carcinoma in situ; CR, complete response; EPI, epirubicin; MMC, mitomy
Loss of Bacillus Calmette-Guérin Viability Adversely Affects the Direct Response of Urothelial Carcinoma Cells to Bacillus Calmette-Guérin Exposure
Keywords: واکسن BCG; urinary bladder; carcinoma; BCG vaccine; cell survival; treatment outcomeBCG, bacillus Calmette-Guérin; CEBP, CCAAT-enhancer-binding protein; hkBCG, heat killed BCG; HMGB1, high mobility group box 1; iNOS, inducible NO synthase; LDH, lactate dehydrogenase
Comparative performance of public and private sector delivery of BCG vaccination: Evidence from Sub-Saharan Africa
Keywords: واکسن BCG; BCG vaccine; Immunizations; Sub-Saharan Africa; Private sector; Private health sector; Tuberculosis;
Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice
Keywords: واکسن BCG; Major depressive disorder; Forced swim test; Tail suspension test; SSRI resistance; BCG vaccine; Serum sickness; Indoleamine-2,3-dioxygenase; Neuroinflammation;
BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9
Keywords: واکسن BCG; MHC-II; Macrophage; Dendritic cells; BCG vaccine; Antigen processing; Toll-like receptor (TLR); MARCH1 ubiquitin ligase; IL-10; CD86; CD80
H2O2 Generation by bacillus Calmette-Guérin Induces the Cellular Oxidative Stress Response Required for bacillus Calmette-Guérin Direct Effects on Urothelial Carcinoma Biology
Keywords: واکسن BCG; urinary bladder; carcinoma; oxidative stress; BCG vaccine; free radicalsAR, Amplex® Red; BCG, bacillus Calmette-Guérin; CBA, coumarin 7-boronic acid; CEBP, CCAAT-enhancer-binding proteins; COS, cellular oxidative stress; DAF-2DA, diaminofluorescein–2 diac
Bacillus Calmette-Guérin Strain Differences Have an Impact on Clinical Outcome in Bladder Cancer Immunotherapy
Keywords: واکسن BCG; Urinary bladder neoplasms; BCG vaccine; BCG Connaught; BCG Tice; Intravesical drug administration; Immunotherapy; Randomized controlled trial; Models; Animal; Flow cytometry;
Impact of Bacillus Calmette-Guérin Moreau vaccine on lung remodeling in experimental asthma
Keywords: واکسن BCG; Asthma; BCG vaccine; Airway remodeling; Eosinophilia; Airway resistance;
Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants
Keywords: واکسن BCG; Mycobacterium bovis BCG Moreau; Multiplex-PCR; BCG vaccine; Identity
A Prospective Comparative Study of Intravesical Bacillus Calmette-Guérin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
Keywords: واکسن BCG; urinary bladder neoplasms; BCG vaccine; BCG Connaught; treatment outcome; JapanBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; NMIBC, nonmuscle invasive bladder cancer; RFS, recurrence-free survival; TURBT, transurethral rese
Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guérin Treatment Failure
Keywords: واکسن BCG; urinary bladder; urinary bladder neoplasms; BCG vaccine; treatment failure; gemcitabineBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonMIBC; NR, n
Randomized Controlled Trial of Oxybutynin Extended Release Versus Placebo for Urinary Symptoms During Intravesical Bacillus Calmette-Guérin Treatment
Keywords: واکسن BCG; carcinoma; transitional cell; urinary bladder neoplasms; BCG vaccine; cholinergic antagonists; comparative effectiveness researchAUA, American Urological Association; BCG, bacillus Calmette-Guérin; EAT, evening after treatment; ER, extended release; MBT,
Efficacy and Safety of Photodynamic Therapy for Recurrent, High Grade Nonmuscle Invasive Bladder Cancer Refractory or Intolerant to Bacille Calmette-Guérin Immunotherapy
Keywords: واکسن BCG; urinary bladder neoplasms; photochemotherapy; chlorin e6; BCG vaccine; treatment failure5-ALA, 5-aminolevulinic acid; AE, adverse effect; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; HAL, hexaminolevulinic acid; LUTS, lower urinary tract symptom
Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations
Keywords: واکسن BCG; BCG vaccine; ATP assay; Attenuated live vaccines; Tuberculosis; Viability
The Value of Transurethral Bladder Biopsy after Intravesical Bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer: A Retrospective, Single Center Study and Cumulative Analysis of the Literature
Keywords: واکسن BCG; urinary bladder; urinary bladder neoplasms; BCG vaccine; biopsy; erythemaBCG, bacillus Calmette-Guérin; FISH, fluorescence in situ hybridization; PDD, photodynamic diagnosis; PPV, positive predictive value; Tis, carcinoma in situ; TURBT, transurethral bla
Anti-Angiogenic Effects of the Superantigen Staphylococcal Enterotoxin B and Bacillus Calmette-Guérin Immunotherapy for Nonmuscle Invasive Bladder Cancer
Keywords: واکسن BCG; urinary bladder; urinary bladder neoplasms; BCG vaccine; enterotoxin B; staphylococcal; methylnitrosoureaBCG, bacillus Calmette-Guérin; BSA, bovine serum albumin; HRP, horseradish peroxidase; IGF, insulin-like growth factor; IGFR-1, IGF receptor-1; MMP, m
Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α
Keywords: واکسن BCG; urinary bladder; urinary bladder neoplasms; BCG vaccine; interferon alfa-2b; prognosis; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Spanish Urological Club for Oncological Treatment; EORTC; European Organization for Research and Treatme
Patterns of in vitro cell-death, metaloproteinase-9 and pro-inflammatory cytokines in human monocytes induced by the BCG vaccine, Moreau strain
Keywords: واکسن BCG; BCG vaccine; Tuberculosis, Monocyte; Apoptosis, Cytokine;
Barriers to implementation of the new targeted BCG vaccination in France: A cross sectional study
Keywords: واکسن BCG; BCG vaccine; Health policy; General practitioner; Infant; Epidemiologic factors; Alternating logistic regression model;